CardioGenics Holdings Inc (CGNH)

Market Cap	14.29K
Revenue (ttm)	n/a
Net Income	-980.79K
EPS	-0.01
Shares Out	142.86M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,500
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.000001 - 0.0001
Beta	58.35
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About CardioGenics Holdings

CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market. Its products include QL Care Analyzer, which is a portable, stand-alone, and automated POC immunoanalyzer; a series of immunoassay tests to enhance the management of patients with cardiovascular diseases; and paramagnetic beads that are used as a solid surface in medical laboratories’ immunoassay testing equipment. The company was formerly known as Jag Media Holdings, Inc. and changed its name to C...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1997
• Employees: 4
• Stock Exchange: OTCMKTS
• Ticker Symbol: CGNH

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 10, 2026

Data Sources Report a data error